Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 11, 2024
Open Peer Review Period: Apr 11, 2024 - May 24, 2024
Date Accepted: Jul 16, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review

Manuilova I, Bossenz J, Weise A, Boehm D, Strantz C, Unberath P, Reimer N, Metzger P, Pauli T, Werle SD, Schulze S, Hiemer S, Ustjanzew A, Kestler HA, Busch H, Brors B, Christoph J

Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review

JMIR Res Protoc 2024;13:e58705

DOI: 10.2196/58705

PMID: 39230952

PMCID: 11411229

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Identifications of similarity metrics for cancer patients: Protocol for a Scoping Review

  • Iryna Manuilova; 
  • Jan Bossenz; 
  • Annemarie Weise; 
  • Dominik Boehm; 
  • Cosima Strantz; 
  • Philipp Unberath; 
  • Niklas Reimer; 
  • Patrick Metzger; 
  • Thomas Pauli; 
  • Silke D. Werle; 
  • Susann Schulze; 
  • Sonja Hiemer; 
  • Arsenij Ustjanzew; 
  • Hans A. Kestler; 
  • Hauke Busch; 
  • Benedikt Brors; 
  • Jan Christoph

ABSTRACT

Background:

Understanding the similarities of cancer patients is essential to advancing personalized medicine, improving patient outcomes, and developing more effective and individualized treatments. It enables researchers to discover important patterns, biomarkers, and treatment strategies that can have a significant impact on cancer research and oncology. In addition, the identification of previously successfully treated patients supports oncologists in making treatment decisions for a new patient who is clinically or molecularly similar to the previous patient.

Objective:

The planned review aims to systematically summarize, map, and describe existing evidence to understand how patient similarity is defined and used in cancer research and clinical care.

Methods:

To systematically identify relevant studies and to ensure reproducibility and transparency of the review process, a comprehensive literature search will be conducted in several bibliographic databases, including Web of Science, PubMed, LIVIVIVO, and MEDLINE, covering the period from 1998 to February 2024. After the initial duplicate deletion phase, a study selection phase will be applied using Rayyan, which consists of three distinct steps: Title and Abstract Screening, Disagreement Resolution, and Full-Text Screening. To ensure the integrity and quality of the selection process, each of these steps is preceded by a pilot testing phase. This methodological process will culminate in the presentation of the final research results in a structured form according to the PRISMA-ScR flowchart. The protocol has been registered in the Journal of Medical Internet Research (JMIR).

Results:

This protocol outlines the methodologies employed in conducting the scoping review. A search of the specified electronic databases and after removing duplicates resulted in 1,183 unique records. As of March 2024, the review process has moved to the full-text evaluation phase. At this stage, data extraction will be conducted using a pre-tested chart template.

Conclusions:

The scoping review protocol, centered on these main concepts, aims to systematically map the available evidence on patient similarity among cancer patients. By defining the types of data sources, approaches, and methods used in the field, and aligning these with the research questions, the review will provide a foundation for future research and clinical application in personalized cancer care. This protocol will guide the literature search, data extraction, and synthesis of findings to achieve the review's objectives.


 Citation

Please cite as:

Manuilova I, Bossenz J, Weise A, Boehm D, Strantz C, Unberath P, Reimer N, Metzger P, Pauli T, Werle SD, Schulze S, Hiemer S, Ustjanzew A, Kestler HA, Busch H, Brors B, Christoph J

Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review

JMIR Res Protoc 2024;13:e58705

DOI: 10.2196/58705

PMID: 39230952

PMCID: 11411229

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.